| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |